Chemomab Therapeutics Ltd
NASDAQ:CMMB
Cash Flow Statement
Cash Flow Statement
Chemomab Therapeutics Ltd
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||
Net Income |
(27)
|
(19)
|
(16)
|
(10)
|
(6)
|
(6)
|
(8)
|
(9)
|
(12)
|
(16)
|
(19)
|
(24)
|
(28)
|
(31)
|
(33)
|
(29)
|
(24)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
6
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
4
|
4
|
3
|
2
|
1
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
Change in Working Capital |
5
|
3
|
3
|
(0)
|
0
|
1
|
(3)
|
(3)
|
(2)
|
(2)
|
1
|
2
|
3
|
4
|
4
|
1
|
(0)
|
|
Cash from Operating Activities |
(16)
N/A
|
(15)
+7%
|
(12)
+20%
|
(10)
+21%
|
(5)
+45%
|
(5)
+12%
|
(9)
-102%
|
(11)
-18%
|
(12)
-12%
|
(15)
-20%
|
(15)
-1%
|
(18)
-18%
|
(20)
-16%
|
(24)
-17%
|
(26)
-7%
|
(26)
+0%
|
(24)
+8%
|
|
Investing Cash Flow | ||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other Items |
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(21)
|
(26)
|
(45)
|
(43)
|
(20)
|
(9)
|
20
|
32
|
26
|
24
|
16
|
|
Cash from Investing Activities |
(0)
N/A
|
(0)
+70%
|
(0)
-67%
|
0
N/A
|
(0)
N/A
|
(0)
+17%
|
(21)
-41 160%
|
(26)
-24%
|
(45)
-76%
|
(43)
+5%
|
(20)
+52%
|
(9)
+54%
|
20
N/A
|
32
+62%
|
26
-19%
|
24
-8%
|
16
-32%
|
|
Financing Cash Flow | ||||||||||||||||||
Net Issuance of Common Stock |
31
|
0
|
3
|
4
|
4
|
49
|
44
|
43
|
59
|
13
|
15
|
15
|
0
|
0
|
2
|
2
|
4
|
|
Other |
(4)
|
(1)
|
1
|
1
|
1
|
3
|
18
|
18
|
2
|
0
|
(15)
|
(15)
|
(1)
|
(1)
|
0
|
0
|
0
|
|
Cash from Financing Activities |
27
N/A
|
(1)
N/A
|
4
N/A
|
4
+15%
|
5
+13%
|
52
+996%
|
62
+20%
|
62
-1%
|
61
-1%
|
13
-78%
|
(0)
N/A
|
(0)
+79%
|
(1)
-2 600%
|
(1)
N/A
|
1
N/A
|
1
-7%
|
4
+599%
|
|
Change in Cash | ||||||||||||||||||
Net Change in Cash |
10
N/A
|
(16)
N/A
|
(9)
+46%
|
(5)
+39%
|
(1)
+89%
|
47
N/A
|
32
-32%
|
25
-23%
|
4
-86%
|
(44)
N/A
|
(35)
+20%
|
(27)
+24%
|
(2)
+94%
|
7
N/A
|
0
-93%
|
(2)
N/A
|
(4)
-166%
|
|
Free Cash Flow | ||||||||||||||||||
Free Cash Flow |
(17)
N/A
|
(15)
+8%
|
(12)
+20%
|
(9)
+23%
|
(5)
+44%
|
(5)
+12%
|
(9)
-104%
|
(11)
-18%
|
(13)
-13%
|
(15)
-19%
|
(15)
N/A
|
(18)
-18%
|
(20)
-15%
|
(24)
-17%
|
(26)
-7%
|
(26)
+0%
|
(24)
+8%
|